Close
4

Athena Athena

X

Find Stiripentol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 131206-47-8 / Stiripentol API manufacturers, exporters & distributors?

Stiripentol manufacturers, exporters & distributors 1

72

PharmaCompass offers a list of Stiripentol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Stiripentol manufacturer or Stiripentol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Stiripentol manufacturer or Stiripentol supplier.

PharmaCompass also assists you with knowing the Stiripentol API Price utilized in the formulation of products. Stiripentol API Price is not always fixed or binding as the Stiripentol Price is obtained through a variety of data sources. The Stiripentol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Stiripentol

Synonyms

49763-96-4, Diacomit, Bcx 2600, 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol, 137767-55-6, Bcx-2600

Cas Number

131206-47-8

Unique Ingredient Identifier (UNII)

R02XOT8V8I

About Stiripentol

Stiripentol is an anticonvulsant drug used in the treatment of epilepsy as an adjunct therapy along with [DB00349] and [DB00313]. This drug is currently approved in the USA, Canada, and European countries as oral tablets marketed as Diacomit. FDA approval of this drug was granted on August 20, 2018,. Unrelated to other anticonvulsants, stiripentol belongs to the group of aromatic allylic alcohols and may potentiate the effect of other antiepileptic drugs (AEDs) due to pharmacokinetic interactions. It elevates the levels of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter that regulates electrical activity in the central nervous system.

DSSTox_CID_28994 Manufacturers

A DSSTox_CID_28994 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_28994, including repackagers and relabelers. The FDA regulates DSSTox_CID_28994 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_28994 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of DSSTox_CID_28994 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

DSSTox_CID_28994 Suppliers

A DSSTox_CID_28994 supplier is an individual or a company that provides DSSTox_CID_28994 active pharmaceutical ingredient (API) or DSSTox_CID_28994 finished formulations upon request. The DSSTox_CID_28994 suppliers may include DSSTox_CID_28994 API manufacturers, exporters, distributors and traders.

click here to find a list of DSSTox_CID_28994 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

DSSTox_CID_28994 USDMF

A DSSTox_CID_28994 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_28994 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_28994 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_28994 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A DSSTox_CID_28994 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_28994 USDMF includes data on DSSTox_CID_28994's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_28994 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of DSSTox_CID_28994 suppliers with USDMF on PharmaCompass.

DSSTox_CID_28994 WC

A DSSTox_CID_28994 written confirmation (DSSTox_CID_28994 WC) is an official document issued by a regulatory agency to a DSSTox_CID_28994 manufacturer, verifying that the manufacturing facility of a DSSTox_CID_28994 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DSSTox_CID_28994 APIs or DSSTox_CID_28994 finished pharmaceutical products to another nation, regulatory agencies frequently require a DSSTox_CID_28994 WC (written confirmation) as part of the regulatory process.

click here to find a list of DSSTox_CID_28994 suppliers with Written Confirmation (WC) on PharmaCompass.

DSSTox_CID_28994 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_28994 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_28994 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture DSSTox_CID_28994 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_28994 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_28994 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of DSSTox_CID_28994 suppliers with NDC on PharmaCompass.

DSSTox_CID_28994 GMP

DSSTox_CID_28994 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of DSSTox_CID_28994 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_28994 GMP manufacturer or DSSTox_CID_28994 GMP API supplier for your needs.

DSSTox_CID_28994 CoA

A DSSTox_CID_28994 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_28994's compliance with DSSTox_CID_28994 specifications and serves as a tool for batch-level quality control.

DSSTox_CID_28994 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_28994 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

DSSTox_CID_28994 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_28994 EP), DSSTox_CID_28994 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_28994 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY